You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
Dermatology

The EPI-CARE and PEDISTAD Studies Provide Real-World Assessment of Atopic Dermatitis Prevalence and Burden in Pediatric Patients

Gain insights into the results of the EPI-CARE and PEDISTAD atopic dermatitis studies – a short soundbite from EAACI 2022.

Antonella Muraro
MD, PhD
Antonella Muraro

Learning objectives

  • Outline the goals and methodologies of the EPI-CARE and PEDISTAD studies
  • Recognize the importance of type 2 inflammation across atopic dermatitis subtypes

Description

EPI-CARE and PEDISTAD are two studies assessing the prevalence and burden of atopic dermatitis. In this soundbite form EAACI 2022, Dr. Antonella Muraro, MD (Centro Allergie Alimentari, Italy), explores their methodologies and explains that type 2 inflammation is the predominant inflammatory pathway across atopic dermatitis subtypes.

MAT-GLB-2204677 V2 10/2022

About this expert

Allergy/Immunology

Antonella Muraro

MD, PhD

Consultant Pediatric Allergist at the Department of Pediatrics of the University of Padova, Italy

See author’s profile
Antonella Muraro

Related resources